Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

An international group of researchers led by Professor Colin Espie from the Nuffield Department of Clinical Neurosciences at the University of Oxford is investigating the impact of the COVID-19 pandemic on sleep and daily rhythms in adults.

An elderly man suffers from insomnia, trying to sleep. Backlight image in blue tones.

During the COVID-19 pandemic, difficulty getting to sleep, difficulty staying asleep and vivid dreaming have been widely reported across the general population. Some people may already have had sleep problems, and these seem to have got worse. Other people who were good sleepers before seem to have developed insomnia.

Sleep is at the heart of physical and mental health. It is essential for tissue repair, cell regeneration, immune functioning, memory functioning and consolation, and for the regulation of daytime emotion. When people are sleep deprived or develop a persistent sleep disorder, the consequences include loss of energy, sleepiness, impaired concentration and memory, and disturbed mood. Inadequate sleep has been associated with increased risk of hypertension and type 2 diabetes, and risk of developing anxiety or depression.

This study will look at changes in sleep quality in relation to social confinement such as a national lockdown or self-isolation, risk of exposure to the virus, and psychological symptoms such as anxiety, depression, and post-traumatic stress. Researchers aim to understand how sleep problems have emerged, and to investigate how sleep during COVID-19 has interacted with lifestyle, health and wellbeing.

Read more on the Nuffield Department of Clinical Neurosciences website

This story is also featured on the University of Oxford website

Similar stories

Human challenge trial launches to study immune response to COVID-19

Clinical Trials Coronavirus COVID-19 General

Though the COVID-19 pandemic has now been active for a year, not much is known about what happens when people who have already had COVID-19 are infected for a second time.

Risk of rare blood clotting higher for COVID-19 than for vaccines

Coronavirus COVID-19 Research

COVID-19 leads to a several-times higher risk of cerebral venous thrombosis (CVT) blood clots than current COVID-19 vaccines.

Alternating vaccines trial expands to include two additional vaccines

Clinical Trials Coronavirus COVID-19 General

Researchers running the Com-Cov study, launched in February to investigate alternating doses of the Oxford-AstraZeneca vaccine and the Pfizer vaccine, have today announced that the programme will be extended to include the Moderna and Novavax vaccines in a new study.

Oxford medical students launch flagship raffle in aid of NHS heroes and lifesaving medical equipment

General

Tingewick, a society formed of medical students from Oxford University, are hosting a virtual charity raffle. With over 70 amazing prizes, ranging from Truck festival tickets to restaurant vouchers to bags of books and even a bike, the raffle is an exciting way to celebrate lockdown lifting by supporting many wonderful Oxfordshire businesses whilst raising lots of money for charity.

Asthma drug budesonide shortens recovery time in non-hospitalised patients with COVID-19

Clinical Trials Coronavirus COVID-19 Research

Inhaled budesonide, a common corticosteroid, is the first widely available, inexpensive drug found to shorten recovery times in COVID-19 patients aged over 50 who are treated at home and in other community settings, reports the PRINCIPLE trial in 1,779 participants.